Nifty
Sensex
:
:
17331.80
58222.10
57.50 (0.33%)
156.63 (0.27%)

Pharmaceuticals & Drugs - Domestic

Rating :
40/99

BSE: 531349 | NSE: PANACEABIO

133.20
06-Oct-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 132.00
  • 135.00
  • 132.00
  • 133.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  21108
  •  28.28
  •  286.00
  •  125.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 816.47
  • 0.76
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 267.35
  • N/A
  • 1.03

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.59%
  • 9.50%
  • 15.60%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 1.31%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.83
  • 2.21
  • 6.72

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -16.68
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -8.61
  • 5.42
  • -15.13

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -3.16
  • 0.01
  • 6.70

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.72
  • -6.74
  • -21.89

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
110.70
132.45
-16.42%
140.73
168.27
-16.37%
155.88
141.76
9.96%
232.17
182.02
27.55%
Expenses
190.51
134.00
42.17%
170.92
167.33
2.15%
144.02
126.61
13.75%
226.15
144.01
57.04%
EBITDA
-79.81
-1.55
-
-30.19
0.94
-
11.86
15.15
-21.72%
6.02
38.01
-84.16%
EBIDTM
-72.10%
-1.17%
-21.45%
0.56%
7.61%
10.69%
2.59%
20.88%
Other Income
12.21
3.23
278.02%
4.05
4.90
-17.35%
1.66
1.89
-12.17%
2.03
2.00
1.50%
Interest
1.25
47.89
-97.39%
30.66
46.91
-34.64%
52.13
45.69
14.09%
50.16
47.51
5.58%
Depreciation
10.05
11.06
-9.13%
11.15
11.58
-3.71%
10.55
11.31
-6.72%
10.90
11.38
-4.22%
PBT
-51.16
-57.27
-
1,608.26
-52.65
-
-49.16
-39.96
-
-53.01
-18.88
-
Tax
4.98
0.08
6,125.00%
370.79
1.49
24,785.23%
0.04
0.04
0.00%
0.00
0.09
-100.00%
PAT
-56.14
-57.35
-
1,237.47
-54.14
-
-49.20
-40.00
-
-53.01
-18.97
-
PATM
-50.71%
-43.30%
879.32%
-32.17%
-31.56%
-28.22%
-22.83%
-10.42%
EPS
-9.16
-9.36
-
201.87
-8.83
-
-8.03
-6.53
-
-8.65
-3.15
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
639.48
661.23
624.80
544.06
456.70
592.79
544.01
653.08
687.19
509.99
608.49
Net Sales Growth
2.40%
5.83%
14.84%
19.13%
-22.96%
8.97%
-16.70%
-4.96%
34.75%
-16.19%
 
Cost Of Goods Sold
330.52
262.20
204.63
156.79
172.24
187.25
149.52
215.81
280.21
214.00
263.41
Gross Profit
308.96
399.02
420.17
387.27
284.45
405.55
394.50
437.27
406.98
295.99
345.08
GP Margin
48.31%
60.35%
67.25%
71.18%
62.28%
68.41%
72.52%
66.96%
59.22%
58.04%
56.71%
Total Expenditure
731.60
675.10
548.18
518.57
589.83
508.26
496.89
541.37
643.31
592.00
694.55
Power & Fuel Cost
-
37.82
30.94
29.74
34.55
33.52
30.55
25.15
30.73
31.74
37.76
% Of Sales
-
5.72%
4.95%
5.47%
7.57%
5.65%
5.62%
3.85%
4.47%
6.22%
6.21%
Employee Cost
-
182.94
156.17
144.42
147.08
151.59
148.12
142.02
135.98
144.92
146.94
% Of Sales
-
27.67%
25.00%
26.54%
32.20%
25.57%
27.23%
21.75%
19.79%
28.42%
24.15%
Manufacturing Exp.
-
78.70
43.22
33.38
44.31
40.05
41.88
39.47
43.97
52.69
67.15
% Of Sales
-
11.90%
6.92%
6.14%
9.70%
6.76%
7.70%
6.04%
6.40%
10.33%
11.04%
General & Admin Exp.
-
53.34
47.48
54.20
71.07
40.39
52.98
39.41
56.82
60.39
73.47
% Of Sales
-
8.07%
7.60%
9.96%
15.56%
6.81%
9.74%
6.03%
8.27%
11.84%
12.07%
Selling & Distn. Exp.
-
48.08
51.18
42.81
31.27
36.98
37.70
44.20
44.20
46.09
48.87
% Of Sales
-
7.27%
8.19%
7.87%
6.85%
6.24%
6.93%
6.77%
6.43%
9.04%
8.03%
Miscellaneous Exp.
-
12.00
14.56
57.24
89.31
18.48
36.14
35.31
51.40
42.17
48.87
% Of Sales
-
1.81%
2.33%
10.52%
19.56%
3.12%
6.64%
5.41%
7.48%
8.27%
9.36%
EBITDA
-92.12
-13.87
76.62
25.49
-133.13
84.53
47.12
111.71
43.88
-82.01
-86.06
EBITDA Margin
-14.41%
-2.10%
12.26%
4.69%
-29.15%
14.26%
8.66%
17.11%
6.39%
-16.08%
-14.14%
Other Income
19.95
10.97
9.98
30.35
5.06
8.23
46.59
20.35
28.48
15.36
5.44
Interest
134.20
180.84
185.34
173.98
104.83
100.58
100.93
127.33
104.53
150.30
103.76
Depreciation
42.65
43.66
45.59
44.13
55.03
58.53
67.95
73.32
67.24
71.10
85.99
PBT
1,454.93
-227.40
-144.32
-162.28
-287.93
-66.35
-75.17
-68.59
-99.41
-288.05
-270.37
Tax
375.81
370.90
1.96
16.95
8.56
9.86
-10.98
1.92
3.08
1.68
-18.76
Tax Rate
25.83%
25.60%
-1.36%
-9.54%
18.58%
-14.86%
16.28%
-10.14%
-3.10%
-1.51%
7.41%
PAT
1,079.12
1,077.88
-146.24
-194.60
37.58
-74.18
-54.75
-18.51
-100.70
-111.56
-234.30
PAT before Minority Interest
1,079.12
1,077.90
-146.20
-194.63
37.52
-76.20
-56.47
-20.85
-102.49
-112.64
-234.30
Minority Interest
0.00
-0.02
-0.04
0.03
0.06
2.02
1.72
2.34
1.79
1.08
0.00
PAT Margin
168.75%
163.01%
-23.41%
-35.77%
8.23%
-12.51%
-10.06%
-2.83%
-14.65%
-21.87%
-38.51%
PAT Growth
733.06%
-
-
-
-
-
-
-
-
-
 
EPS
176.04
175.84
-23.86
-31.75
6.13
-12.10
-8.93
-3.02
-16.43
-18.20
-38.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
848.79
-228.69
198.79
350.40
308.68
355.68
448.61
471.29
512.72
625.69
Share Capital
6.13
6.13
6.13
6.13
6.13
6.13
22.43
22.43
6.13
6.13
Total Reserves
842.67
-234.82
160.66
344.27
302.55
349.55
426.18
448.76
506.59
619.56
Non-Current Liabilities
103.75
959.99
740.66
70.08
591.13
718.78
1,100.11
918.47
767.07
865.20
Secured Loans
0.24
675.05
583.55
8.90
560.45
704.57
866.08
721.77
581.77
688.31
Unsecured Loans
33.87
60.03
29.58
37.22
10.26
9.49
1.00
1.20
1.40
1.60
Long Term Provisions
29.23
30.65
42.74
39.78
26.54
18.36
184.42
180.43
180.47
171.27
Current Liabilities
802.77
449.09
622.14
938.26
695.52
689.13
474.80
706.03
826.82
509.96
Trade Payables
259.78
246.66
198.85
269.71
277.19
248.60
187.87
209.13
252.11
175.69
Other Current Liabilities
530.52
189.06
242.12
585.25
242.00
237.52
93.60
194.85
251.91
49.82
Short Term Borrowings
0.00
0.00
3.57
69.39
164.88
190.71
191.82
295.84
320.67
274.00
Short Term Provisions
12.47
13.37
177.60
13.92
11.44
12.30
1.51
6.21
2.13
10.45
Total Liabilities
1,752.33
1,177.39
1,558.55
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20
Net Block
589.28
608.70
657.39
805.56
948.97
1,001.37
1,071.11
1,144.30
1,275.54
1,154.49
Gross Block
1,284.46
1,266.39
1,282.22
1,392.90
1,605.84
1,600.07
1,620.29
1,633.48
1,697.63
1,694.13
Accumulated Depreciation
695.18
657.69
624.84
587.34
656.87
598.70
549.18
489.18
422.09
539.64
Non Current Assets
711.78
666.41
875.27
847.84
1,027.55
1,070.91
1,475.22
1,573.49
1,739.28
1,574.45
Capital Work in Progress
17.26
34.42
24.01
22.51
39.92
30.41
115.78
110.31
116.55
135.26
Non Current Investment
0.07
0.07
5.58
5.33
5.25
7.01
5.19
10.20
15.97
16.51
Long Term Loans & Adv.
21.46
17.62
187.70
13.33
28.01
22.03
236.71
262.44
274.94
266.34
Other Non Current Assets
83.71
5.61
0.60
1.12
5.39
10.09
1.26
1.07
0.35
1.85
Current Assets
1,040.55
510.97
683.27
507.89
564.83
703.22
549.38
525.72
372.81
433.75
Current Investments
5.00
0.00
0.00
0.00
2.03
0.27
3.52
4.98
0.00
5.99
Inventories
212.72
174.14
147.69
81.43
334.21
315.55
305.24
310.22
219.81
267.94
Sundry Debtors
131.66
84.68
68.52
88.73
136.01
142.17
141.67
98.57
94.93
69.86
Cash & Bank
583.28
135.79
89.75
23.48
23.24
14.13
22.93
52.40
24.78
39.23
Other Current Assets
107.89
52.64
335.69
273.23
69.36
231.09
76.02
59.55
33.29
50.73
Short Term Loans & Adv.
59.15
63.72
41.62
41.02
59.30
56.21
66.76
50.15
24.72
44.44
Net Current Assets
237.78
61.88
61.13
-430.38
-130.69
14.08
74.58
-180.31
-454.01
-76.21
Total Assets
1,752.33
1,177.38
1,558.54
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
-108.44
106.76
-30.47
104.80
118.02
130.67
90.69
37.23
53.73
-24.02
PBT
1,448.81
-145.03
-177.34
46.23
-66.14
-67.18
-18.93
-99.41
-110.96
-253.06
Adjustment
-1,455.07
230.88
253.04
-70.58
166.62
149.57
148.75
167.45
59.92
161.18
Changes in Working Capital
301.53
21.91
-97.50
127.32
21.45
43.32
-58.26
-25.16
107.22
68.23
Cash after chg. in Working capital
295.26
107.76
-21.80
102.97
121.93
125.71
71.56
42.88
56.18
-23.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-403.70
-1.00
-8.67
1.83
-3.91
4.96
19.13
-5.65
-2.45
-0.37
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
1,282.57
-47.68
-34.76
-5.27
55.29
-25.83
16.44
-37.38
-37.60
-61.19
Net Fixed Assets
-26.71
28.01
223.59
488.74
-15.06
-27.48
11.93
-29.48
-5.26
-31.39
Net Investments
0.00
54.26
-51.99
342.34
0.00
49.78
0.00
-0.46
-122.35
-13.38
Others
1,309.28
-129.95
-206.36
-836.35
70.35
-48.13
4.51
-7.44
90.01
-16.42
Cash from Financing Activity
-1,175.85
-47.11
90.74
-101.14
-164.35
-106.96
-117.38
-0.70
-30.26
104.89
Net Cash Inflow / Outflow
-1.72
11.97
25.51
-1.61
8.97
-2.13
-10.25
-0.85
-14.13
19.68
Opening Cash & Equivalents
52.08
40.22
14.47
16.44
7.47
9.59
19.97
20.84
34.95
15.16
Closing Cash & Equivalent
50.35
52.08
40.22
14.47
16.44
7.47
9.73
19.99
20.84
34.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
138.58
-37.34
27.23
57.21
50.40
58.07
-4.43
-0.75
13.96
34.08
ROA
73.58%
-10.69%
-13.36%
2.55%
-4.53%
-2.97%
-1.01%
-4.87%
-5.47%
-11.36%
ROE
347.66%
0.00%
-75.26%
11.39%
-22.94%
-34.38%
0.00%
-253.03%
-76.49%
-71.43%
ROCE
221.15%
5.36%
-0.38%
13.44%
2.63%
2.76%
9.93%
0.45%
3.37%
-11.89%
Fixed Asset Turnover
0.55
0.51
0.41
0.30
0.37
0.35
0.40
0.41
0.30
0.37
Receivable days
56.79
42.68
52.75
89.81
85.16
92.84
67.10
51.36
58.89
41.39
Inventory Days
101.55
89.66
76.86
166.09
198.91
203.06
171.89
140.68
174.32
195.55
Payable days
352.48
397.33
178.20
213.56
186.55
163.89
130.73
137.37
148.94
82.64
Cash Conversion Cycle
-194.15
-264.98
-48.60
42.34
97.52
132.00
108.26
54.67
84.27
154.30
Total Debt/Equity
0.04
-3.58
4.45
1.85
3.05
2.79
-100.22
93.42
12.38
4.69
Interest Cover
9.01
0.22
-0.02
1.44
0.34
0.33
0.85
0.05
0.26
-1.44

News Update:


  • Panacea Biotec - Quarterly Results
    9th Aug 2022, 15:30 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.